Devin M. Swanson

Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain

Joseph R. Ghilardi, Heidi Röhrich, Theodore H. Lindsay et al. · Journal of Neuroscience · 2005 · 379 citations · Full text

Life Sciences, Cancer Biology, Neuroscience +17

Identification and Biological Evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist

Devin M. Swanson, Adrienne E. Dubin, Chandra Shah et al. · Journal of Medicinal Chemistry · 2004 · 184 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs

Anindya Bhattacharya, Brian Scott, Nadia Nasser et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 74 citations

Medicine, Medicinal Chemistry, Pharmacology +14

4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate

Michael A. Letavic, Brad M. Savall, Brett D. Allison et al. · Journal of Medicinal Chemistry · 2017 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

James R. Shoblock, Natalie Welty, Diane Nepomuceno et al. · Psychopharmacology · 2009 · 52 citations

Life Sciences, Neuroscience, Pharmacology +14